Skip to content
TrackPodcasts
scienceApr 26, 202448:28pending

Transforming CLTI with Dan Rose, former CEO of LimFlow

About this episode

Transforming the outcomes for a disease takes great innovation. With that, you need impeccable dedication and leadership for the team to deliver on taking a solution to market. Former CEO of LimFlow, Dan Rose, is one such leader who can attest to the trials and tribulations of this challenging journey.

Dan joins this episode to share the story of how LimFlow’s technology has gone from an idea with potential, to a life-saving solution. In achieving this, the company has been able to re-design the anatomy of the body to offer hope to those suffering the effects of Chronic Limb-Threatening Ischemia (CLTI).

During this discussion you will learn the despairing depths of a disease that is quite literally ravaging people’s lives. Dan shares how he was able to build a world class team from across the globe to design a new option for patients where none existed before. Navigating numerous challenges, raising significant amounts of capital, and leading the company to a successful acquisition by Inari Medical; From beginning to end, this tale will truly leave you informed and inspired.

Get every episode summarized

Each time The Medtech Impact Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Transforming CLTI with Dan Rose, former CEO of LimFlow

The Medtech Impact Podcast

0:00
48:28

More episodes

More from The Medtech Impact Podcast

View all episodes →